Dr. Katherine Broadway is a microbiologist subject matter expert (SME) supporting the Defense Threat Reduction Agency (DTRA)’s Technical Reachback Division. She is currently leading the research and development efforts for the Biological Team, and routinely performs atmospheric dispersion modeling and epidemiological projections of disease spread. Dr. Broadway earned her Ph.D. from Virginia Tech in 2018, where her studies focused on the development and efficacy of microbial-based cancer therapeutics. Her background expertise in the field of biodefense includes novel biological detector engineering for the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), at various levels of technological readiness. Dr. Broadway’s research interests span the areas of bacterial genetic engineering, cancer biology, bioinformatics, and biological surveillance strategies.
Dr. Katherine Broadway is a microbiologist subject matter expert (SME) supporting the Defense Threat Reduction Agency (DTRA)’s Technical Reachback Division. She is currently leading the research and development efforts for the Biological Team, and routinely performs atmospheric dispersion modeling and epidemiological projections of disease spread. Dr. Broadway earned her Ph.D. from Virginia Tech in 2018, where her studies focused on the development and efficacy of microbial-based cancer therapeutics. Her background expertise in the field of biodefense includes novel biological detector engineering for the U.S. Army Combat Capabilities Development Command Chemical Biological Center (DEVCOM CBC), at various levels of technological readiness. Dr. Broadway’s research interests span the areas of bacterial genetic engineering, cancer biology, bioinformatics, and biological surveillance strategies.